Financial Performance - Operating revenue for Q1 2023 was CNY 114,424,720.16, representing a 2.30% increase compared to CNY 111,850,834.80 in Q1 2022[11] - Net profit attributable to shareholders for Q1 2023 was CNY 3,039,686.80, a decrease of 2.69% from CNY 3,123,662.53 in the same period last year[11] - Basic earnings per share decreased by 28.57% to CNY 0.05 in Q1 2023, down from CNY 0.07 in Q1 2022[11] - Total operating revenue for Q1 2023 was ¥114,424,720.16, an increase of 3.1% compared to ¥111,850,834.80 in Q1 2022[36] - Net profit for Q1 2023 was ¥3,039,686.80, a decrease of 2.7% from ¥3,123,662.53 in Q1 2022[38] - Earnings per share for Q1 2023 were ¥0.05, down from ¥0.07 in Q1 2022[38] Cash Flow - The net cash flow from operating activities for Q1 2023 was negative CNY 27,943,389.96, a significant decline compared to negative CNY 6,764,688.31 in Q1 2022[11] - Operating cash inflow for Q1 2023 was CNY 98,391,137.02, a decrease of 19.1% compared to CNY 121,697,359.02 in Q1 2022[43] - Cash received from sales of goods and services was CNY 97,679,198.37, a decline of 19.6% from CNY 121,514,155.90 in Q1 2022[43] - Cash paid for purchasing goods and services was CNY 117,663,477.05, an increase from CNY 116,025,601.58 in Q1 2022[43] - The company reported a net increase in cash and cash equivalents of CNY -7,067,050.14 for Q1 2023, compared to CNY -12,559,732.87 in Q1 2022[44] - Cash inflow from financing activities was CNY 10,000,000.00, up from CNY 6,000,000.00 in Q1 2022, resulting in a net cash flow of CNY 2,488,805.58[44] Assets and Liabilities - Total assets as of March 31, 2023, amounted to CNY 281,750,523.50, reflecting a 1.27% increase from CNY 278,221,035.99 at the end of 2022[11] - The company's asset-liability ratio for the parent company was 8.76%, up from 7.92% at the end of 2022[11] - Total liabilities as of March 31, 2023, were CNY 36,676,172.65, compared to CNY 36,234,940.91 at the end of 2022, reflecting an increase of about 1.2%[30] - Total current assets amounted to CNY 203,456,009.92, slightly up from CNY 203,125,243.67 on December 31, 2022, indicating a growth of approximately 0.16%[28] - Accounts receivable increased significantly to CNY 62,451,322.00 from CNY 42,967,662.74, representing a growth of about 45.5%[28] - Cash and cash equivalents decreased to CNY 33,667,006.63 from CNY 40,734,056.77, a decline of approximately 17.4%[28] Shareholder Information - Major shareholders include Chen Zhiqiang with a 30.02% stake, Liao Xinglie with 10.68%, and Luo Yulong with 3.34%[20] - The total equity attributable to shareholders reached CNY 245,074,350.85, up from CNY 241,986,095.08, indicating an increase of about 1.7%[30] Compliance and Legal Matters - The company has no ongoing litigation or arbitration matters during the reporting period[24] - There were no external loan provisions or related party fund transfers during the reporting period[24] - The company has successfully maintained compliance with all disclosed commitments during the reporting period[24] - The company has not engaged in any share repurchase activities during the reporting period[24] - The company has not faced any investigations or penalties during the reporting period[24] Operational Expenses - Management expenses increased due to the trial production phase of a subsidiary, leading to higher personnel costs and operational expenses[14] - Financial expenses decreased as the company did not incur discount interest due to sufficient funds and increased bank acceptance bill receipts[14] - Research and development expenses for Q1 2023 were ¥3,218,795.00, a decrease of 15% from ¥3,787,902.68 in Q1 2022[37] - Financial expenses decreased significantly to ¥162,500.99 in Q1 2023 from ¥591,799.71 in Q1 2022, a reduction of 72.5%[37] Investment Activities - The company’s investment activities generated a significant cash inflow due to the maturity of financial products purchased in the previous year[14] - The total revenue for the reporting period reached 50,359,070, with a year-on-year growth of 80.80% compared to 46,928,880[20] - The company reported an investment income of ¥168,689.11 in Q1 2023, compared to a loss of ¥11,807.63 in Q1 2022[37] - Investment cash inflow totaled CNY 22,868,689.11, with a net cash flow from investment activities of CNY 18,387,534.91, a significant improvement from CNY -6,547,275.69 in Q1 2022[44]
新威凌(871634) - 2023 Q1 - 季度财报